MYLAN-TERAZOSIN
MYLAN-TERAZOSIN
Discontinued
DIN Number
02396319
Drug Class
Human
Market Date
Nov 9, 2012
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02396319
AIG Number0121210004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04CA03 TERAZOSIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TERAZOSIN HYDROCHLORIDEActive
Strength: 10 MG
Monograph: TERAZOSIN HYDROCHLORIDE